Cargando…

The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study

INTRODUCTION: Second-generation antipsychotics show significant interpatient variability in treatment response and side-effect profiles, and the majority of patients with schizophrenia require multiple treatment changes. This subgroup analysis of the ESCAPE study evaluated the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Ying, Yu, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407443/ https://www.ncbi.nlm.nih.gov/pubmed/28461752 http://dx.doi.org/10.2147/NDT.S132363

Ejemplares similares

Effectiveness of amisulpride in Chinese patients with predominantly negative symptoms of schizophrenia: a subanalysis of the ESCAPE study
por: Liang, Ying, et al.
Publicado: (2017)

Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia
por: Liu, Jin-Ling, et al.
Publicado: (2023)

A Comparative Study between Olanzapine and Risperidone in the Management of Schizophrenia
por: Shoja Shafti, Saeed, et al.
Publicado: (2014)

Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis
por: Men, Peng, et al.
Publicado: (2018)

Sexual dysfunction in male schizophrenia remitted patients treated with risperidone and olanzapine
Publicado: (2022)

Olanzapine has better efficacy compared to risperidone for treatment of negative symptoms in schizophrenia
por: Suresh Kumar, P. N., et al.
Publicado: (2016)

Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia
por: Vadlamani, Laxmi Naresh, et al.
Publicado: (2017)

Effect of olanzapine combined with risperidone in the treatment of schizophrenia and its influence on cognitive function
por: Yang, Lujie, et al.
Publicado: (2021)

Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial
por: Stabell, L.A, et al.
Publicado: (2023)

The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8‐week, prospective, open‐label, multicenter, single‐arm study
por: Liang, Ying, et al.
Publicado: (2016)

A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2004)

Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
por: Gabriel, Adel
Publicado: (2010)

Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study
por: Woo, Young Sup, et al.
Publicado: (2022)

Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study
por: Bahk, W.-M., et al.
Publicado: (2023)

Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study
por: Kumar, Subodh, et al.
Publicado: (2014)

Update on the management of symptoms in schizophrenia: focus on amisulpride
por: Mortimer, Ann M
Publicado: (2009)

Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
por: Gao, Keming, et al.
Publicado: (2013)

Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
por: Dilla, Tatiana, et al.
Publicado: (2014)

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis
por: Ye, Wenyu, et al.
Publicado: (2012)

Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study
por: Hong, Jihyung, et al.
Publicado: (2012)

Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded study
por: Ganguli, Rohan, et al.
Publicado: (2008)

Direct metabolic effects of risperidone and olanzapine in Japanese schizophrenic patients
por: Nagamine, Takahiko
Publicado: (2007)

Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021)

Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021)

Safety and tolerability of antipsychotics: focus on amisulpride
por: Juruena, Mario F, et al.
Publicado: (2010)

RISPERIDONE IN SCHIZOPHRENIA
por: Agashe, Mohan, et al.
Publicado: (1999)

RISPERIDONE IN SCHIZOPHRENIA
por: Kumar, P.N. Suresh
Publicado: (1999)

Population pharmacokinetics of Amisulpride in Chinese patients with schizophrenia with external validation: the impact of renal function
por: Li, Anning, et al.
Publicado: (2023)

Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia
por: Sathish Kumar, S. V., et al.
Publicado: (2015)

Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients
por: Aquino, Adriano, et al.
Publicado: (2018)

Metabolic derangements with olanzapine and risperidone in schizophrenia spectrum and other psychotic disorders: A 24-week prospective study
por: Rikhari, Praveen, et al.
Publicado: (2022)

A cost-utility analysis of Amisulpride and Paliperidone in the treatment of Schizophrenia
por: Abdall-Razak, Ali, et al.
Publicado: (2019)

A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine
por: Nagaraj, Anil Kumar M., et al.
Publicado: (2009)

Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro)
por: Kjelby, Eirik, et al.
Publicado: (2023)

Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)
por: García-Cabeza, Ignacio, et al.
Publicado: (2001)

Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids
por: He, Sidi, et al.
Publicado: (2020)

PM391. THE USE OF AMISULPRIDE IN TREATMENT OF PATIENTS WITH RESIDUAL SCHIZOPHRENIA
por: Janjic, Vladimir, et al.
Publicado: (2016)

Hyperprolactinaemia with amisulpride
por: Raj, Rajnish, et al.
Publicado: (2008)

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
por: Hori, Hikaru, et al.
Publicado: (2018)

Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study
por: Kumari, Veena, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8c8g579vvfcsim09s37al4s57r